Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 196 M204 M163 M141 M202 M180 M 686 M Research & development —————— — Operating income 221 M193 M234 M156 M19 M95 M 504 M Non-Operating Income, Total -1 M-1 M0-1 M0-2 M -3 M Interest expense, net of interest capitalized 51 M53 M53 M63 M64 M68 M 248 M Non-Operating Income, excl. Interest Expenses -52 M-54 M-53 M-64 M-64 M-70 M -251 M Unusual income/expense —————— — Pretax income 170 M139 M181 M92 M-45 M26 M 254 M Equity in earnings ——1 M0—— — Taxes 43 M35 M40 M21 M-2 M2 M 61 M Non-controlling/minority interest —————— — After tax other income/expense -6 M19 M-3 M26 M5 M-3 M 25 M Net income before discontinued operations 127 M104 M142 M71 M-43 M24 M 194 M Discontinued operations —————— — Net income 127 M104 M142 M71 M-43 M24 M 194 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 127 M104 M142 M71 M-43 M24 M 194 M Basic earnings per share (Basic EPS) 0.420.350.480.23-0.140.08 0.65 Diluted earnings per share (Diluted EPS) 0.420.340.480.24-0.140.08 0.66 Average basic shares outstanding 302.2 M301.2 M297.1 M299.3 M296.7 M296.6 M — Diluted shares outstanding 303.2 M301.6 M297.6 M299.8 M296.7 M296.7 M — EBITDA 366 M333 M376 M316 M119 M252 M 1.06 B EBIT 235 M203 M250 M167 M-20 M107 M 504 M Cost of revenue 1.68 B1.78 B1.76 B1.8 B1.85 B1.9 B 7.3 B Other cost of goods sold 1.68 B1.78 B1.76 B1.8 B1.85 B1.9 B 7.3 B Depreciation & amortization (cash flow) 131 M130 M126 M149 M139 M145 M 559 M